ARCUTIS BIOTHERAPEUTIC
11.26
26-نوفمبر-24 14:44:12
15 متأخرة بدقائق
الأسهم
+0.49
+4.55%
نطاق اليوم
10.57 - 11.50
ISIN
N/A
المصدر
NASDAQ
-
23 يوليو 2024 08:00:01 بحسب Nasdaq GlobeNewswire
-
Arcutis to Host ZORYVE® (Roflumilast) Cream 0.15% FDA Approval Call With KOL
22 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
09 يوليو 2024 16:53:01 بحسب Nasdaq GlobeNewswire
-
Arcutis Provides Update on sNDA for Roflumilast Cream 0.15% for Atopic Dermatitis
09 يوليو 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 يوليو 2024 16:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 يونيو 2024 16:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
03 يونيو 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Announces First Quarter 2024 Financial Results and Provides Business Update
14 مايو 2024 16:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 مايو 2024 16:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024
29 أبريل 2024 16:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Appoints David Topper as Chief Financial Officer
10 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 أبريل 2024 16:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis to Present at the 23rd Annual Needham Virtual Healthcare Conference
28 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Promotes Todd Tucker to Chief Human Resources Officer
11 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire
-
09 مارس 2024 16:00:00 بحسب Nasdaq GlobeNewswire
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 مارس 2024 16:00:00 بحسب Nasdaq GlobeNewswire
-
04 مارس 2024 16:00:00 بحسب Nasdaq GlobeNewswire